Darnytsia Medicines Conquer the World: Ukrainian Quality on the Global Map of Health

Darnytsia Pharmaceutical Company is confidently expanding its international presence, proving that Ukrainian medicines meet global standards and earn the trust of millions of patients worldwide.

Darnytsia’s high-quality medicines are registered in various corners of the world:

•    Asia-Pacific region: Australia, New Zealand, Singapore, Malaysia
•    Europe: Bosnia and Herzegovina, Lithuania, Poland, Moldova, Estonia
•    Asia and the Caucasus: Azerbaijan, Armenia, Georgia, Kazakhstan, Kyrgyzstan, Mongolia, Tajikistan, Turkmenistan, Uzbekistan.

Darnytsia confirms its commitment to the highest quality standards, continually passing strict international inspections. This year, the company has already successfully undergone inspections by Ukrainian, Lithuanian, and Libyan regulatory authorities. By the end of the year, another inspection is expected from the EU regulator, two inspections by regulators from Asian countries (Kazakhstan, Uzbekistan), and an audit by the regulatory authority of Saudi Arabia (MENA).

This once again proves that Darnytsia not only complies with cutting-edge pharmaceutical standards but also opens its facilities to scrutiny by the most demanding international experts. 

Darnytsia guarantees strict quality control at every stage of production and safety for patients in all countries where its products are available.

That is why patients and medical professionals in more than 20 countries around the world trust Darnytsia.

“We prove every day that a Ukrainian pharmaceutical product can be the number-one choice not only at home but across the world. For us, quality is not just a standard, but a global responsibility. We are proud that, thanks to our medicines, patients from different continents receive modern support in the fight against the most complex diseases,” says Anna Pavliuk-Havrylova, Head of International Registration and Market Expansion at Darnytsia Pharmaceutical Company.